Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Diabetes Mellitus, Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1675
|
954
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Ankylosing spondylitis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
710
|
609
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Eosinophil count procedure
|
phenotype |
|
Laboratory Procedure
|
610
|
1144
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Psoriasis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
1308
|
705
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Chronic venous insufficiency
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
25
|
3
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
peak expiratory flow (procedure)
|
phenotype |
|
Laboratory Procedure
|
74
|
119
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1883
|
1172
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Inflammatory Bowel Diseases
|
group |
Digestive System Diseases
|
Disease or Syndrome
|
1577
|
605
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Forced expiratory volume function
|
phenotype |
|
Organ or Tissue Function
|
272
|
1169
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Cholangitis, Sclerosing
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
188
|
276
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Ulcerative Colitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1458
|
827
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Primary antiphospholipid syndrome
|
disease |
Immune System Diseases
|
Disease or Syndrome
|
29
|
1
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Leukocyte adhesion deficiency type 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases
|
Disease or Syndrome
|
114
|
26
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Stage IV Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Stage III Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Stage IIB Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Respiratory Tract Diseases
|
Disease or Syndrome
|
1410
|
80
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Parkinson's disease psychosis
|
disease |
|
Mental or Behavioral Dysfunction
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |